139 related articles for article (PubMed ID: 3719056)
21. Further results on a multiple-testing procedure for clinical trials.
Seigel D; Milton RC
Biometrics; 1983 Dec; 39(4):921-8. PubMed ID: 6671127
[TBL] [Abstract][Full Text] [Related]
22. A treatment allocation procedure for sequential clinical trials.
Begg CB; Iglewicz B
Biometrics; 1980 Mar; 36(1):81-90. PubMed ID: 7370375
[TBL] [Abstract][Full Text] [Related]
23. Large sample tests for binary outcomes in fixed-dose combination drug studies.
Wang SJ; Hung HM
Biometrics; 1997 Jun; 53(2):498-503. PubMed ID: 9192448
[TBL] [Abstract][Full Text] [Related]
24. A group sequential type design for three-arm non-inferiority trials with binary endpoints.
Li G; Gao S
Biom J; 2010 Aug; 52(4):504-18. PubMed ID: 20645389
[TBL] [Abstract][Full Text] [Related]
25. Randomization procedures in orthopaedic trials.
Randelli P; Arrigoni P; Lubowitz JH; Cabitza P; Denti M
Arthroscopy; 2008 Jul; 24(7):834-8. PubMed ID: 18589273
[TBL] [Abstract][Full Text] [Related]
26. A sample-size-optimal Bayesian procedure for sequential pharmaceutical trials.
Cressie N; Biele J
Biometrics; 1994 Sep; 50(3):700-11. PubMed ID: 7981396
[TBL] [Abstract][Full Text] [Related]
27. A note on P-values under group sequential testing and nonproportional hazards.
Gillen DL; Emerson SS
Biometrics; 2005 Jun; 61(2):546-51. PubMed ID: 16011703
[TBL] [Abstract][Full Text] [Related]
28. An optimal design for screening trials.
Wang YG; Leung DH
Biometrics; 1998 Mar; 54(1):243-50. PubMed ID: 9544519
[TBL] [Abstract][Full Text] [Related]
29. [Randomization and stratification in clinical research (author's transl)].
Fei LM; Zeng XJ
Zhonghua Yi Xue Za Zhi; 1981 Jun; 61(6):331-4. PubMed ID: 6796230
[No Abstract] [Full Text] [Related]
30. A generic minimization random allocation and blinding system on web.
Cai H; Xia J; Xu D; Gao D; Yan Y
J Biomed Inform; 2006 Dec; 39(6):706-19. PubMed ID: 16616696
[TBL] [Abstract][Full Text] [Related]
31. Multistage test procedure for testing Blackwelder's hypothesis of equivalence.
Lakshminarayanan MY; Patel HI; Stager WJ
J Biopharm Stat; 1994 Jul; 4(2):165-71. PubMed ID: 7951272
[TBL] [Abstract][Full Text] [Related]
32. Treatment allocation for nonlinear models in clinical trials: the logistic model.
Begg CB; Kalish LA
Biometrics; 1984 Jun; 40(2):409-20. PubMed ID: 6487725
[TBL] [Abstract][Full Text] [Related]
33. How order affects the sign test.
Rayner JC; Best DJ
Biometrics; 1997 Dec; 53(4):1416-21. PubMed ID: 9453784
[TBL] [Abstract][Full Text] [Related]
34. Cox regression methods for two-stage randomization designs.
Lokhnygina Y; Helterbrand JD
Biometrics; 2007 Jun; 63(2):422-8. PubMed ID: 17425633
[TBL] [Abstract][Full Text] [Related]
35. Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients.
Freidlin B; Simon R
Clin Cancer Res; 2005 Nov; 11(21):7872-8. PubMed ID: 16278411
[TBL] [Abstract][Full Text] [Related]
36. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
Schwartz TA; Denne JS
Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
[TBL] [Abstract][Full Text] [Related]
37. Randomization as a basis for inference in noninferiority trials.
Wiens BL
Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
[TBL] [Abstract][Full Text] [Related]
38. Statistical inference and the design of clinical trials.
Berry DA
Biomedicine; 1980 Feb; 32(1):4-7. PubMed ID: 7370380
[TBL] [Abstract][Full Text] [Related]
39. Factorial designs for randomized clinical trials.
Byar DP; Piantadosi S
Cancer Treat Rep; 1985 Oct; 69(10):1055-63. PubMed ID: 4042085
[No Abstract] [Full Text] [Related]
40. Individual allocation had an advantage over cluster randomization in statistical efficiency in some circumstances.
Hewitt CE; Torgerson DJ; Miles JN
J Clin Epidemiol; 2008 Oct; 61(10):1004-8. PubMed ID: 18411038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
